Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer
NCT ID: NCT02854982
Last Updated: 2025-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
900 participants
OBSERVATIONAL
2015-09-01
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life and Shared Decision Making in Prostate Cancer
NCT03948204
Quality of Life Study for Prostate Cancer Patients
NCT00561444
Assessing Quality of Life of Patients With Prostate Cancer
NCT00041301
MRI in Diagnosing Prostate Cancer
NCT01292291
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03789253
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prostate Cancer
Group drawn of the case group of the case control study, entitled EPICAP
therapeutic management of the prostate Cancer as usual
No Prostate Cancer
Group drawn of the control group of the case control study, entitled EPICAP
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
therapeutic management of the prostate Cancer as usual
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* under 75 and residing in the Hérault department at diagnosis
* recruited in the EPICAP study
* controls (without prostate cancer) recruited in the EPICAP study
* matched to cases on age (5 years)
* residing in the Hérault department
Exclusion Criteria
* non-exposed group:
* diagnosis of prostate cancer set in the range
75 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
References
Explore related publications, articles, or registry entries linked to this study.
Houede N, Rebillard X, Bouvet S, Kabani S, Fabbro-Peray P, Tretarre B, Menegaux F. Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study. BMC Cancer. 2020 Aug 12;20(1):757. doi: 10.1186/s12885-020-07244-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LIGUE/2014/NH-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.